Global Kidney/Renal Function Test Market Size, Trends and Growth Opportunity, By Product Type (Dipsticks, Reagents, Disposables), By Test Type (Urine Tests, Blood Tests), By End User (Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes, Others), By Region and forecast till 2030. 

 

Global Kidney/Renal Function Test Market 

 

Global Kidney/Renal Function Test Market was valued at USD 875.9 million in 2022 and is slated to reach USD 1417.35 million by 2030 at a CAGR of 6.27% from 2023-2030.
The kidney/renal function tests are performed to identify any kidney function problem. These disorders frequently cause trouble urinating due to an increase in body fluids, blood in the urine, swelling in the hands or feet, and facial and hand swelling. End-stage kidney (or renal) disease (ESRD) can develop over time as a result of kidney or renal disorders. It has grown to be a significant public health problem. They are commonly utilised for the accurate detection of various illnesses.

 

Market Drivers
 

The global increase in the prevalence of chronic renal disease is largely to blame for the market's expansion. The National Kidney Foundation estimates that 10% of the world's population suffers from chronic kidney disease (CKD). Around 1.13 billion people worldwide have hypertension, according to WHO facts for 2019. Between 2014 and 2016, about 75% of kidney failure was brought on by diabetes and hypertension. The market will expand as a result of the rising demand for tests for early illness detection. So, it encourages market expansion. The market is expected to develop due to the increased implementation of digital urinalysis, which identifies the rising need for home diagnostics. In order to encourage individuals to choose renal testing for proteins, Healthy.io, an Israeli start-up in the digital health industry, created an at-home smartphone urine test that has received FDA clearance. Kidney disease consequences can be reduced with early identification. Additionally, the company's Dip.io urinalysis test uses single-use cups and strips along with a smartphone camera to interpret and read the results. This component so accelerates market expansion.  

 

Market Restraints
 

Over a forecast period, the side effects of these renal medications could slow the market's growth worldwide. The market's expansion may be hampered by side effects like nausea, fever, and rashes. Reduced blood cell counts, as well as liver and renal issues indicated by changes in blood tests, are other uncommon, more severe adverse effects. As a result, these elements cause market obstacles.
Impact of COVID-19
Numerous non-essential medical procedures have been postponed or stopped as a result of the pandemic. This includes typical kidney/renal function testing, which in many instances have been rescheduled or delayed. As a result, the market growth has been impacted and the demand for kidney/renal function tests has fallen. Remote monitoring of kidney/renal function tests has received more attention as a result of the requirement for social isolation and less communication with medical professionals. New technologies and tools have been created as a result, allowing patients to monitor their kidney function from the convenience of their homes, such as home-based kidney function tests and telehealth services. Additionally, COVID-19 has led to an increase in the number of patients needing dialysis as a result of the virus's impact on the kidneys. The market for kidney/renal function tests has benefited from the increased demand for dialysis equipment, supplies, and other items that has resulted from this.

 

Market Segmentation
 

Global Kidney/Renal Function Test Market is segmented into Product Type, Test Type, & End User. By Product Type such as Dipsticks, Reagents, Disposables. By Test Type such as Urine Tests, Blood Tests. By End User such as Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes, Others.

 

Regional Analysis
 

Global Kidney/Renal Function Test Market is segmented into five regions Americas, Europe, Asia-Pacific, and the Middle East & Africa. Throughout the anticipated period, North America dominated the market growth for kidney/renal function tests due to the widespread presence of supportive government initiatives and the persistent implementation by healthcare organisations in the area. A high rate of market expansion is anticipated in Asia-Pacific as a result of increased awareness-raising efforts by the government and pharmaceutical companies as well as the prevalence of generic manufacturers. industry expansion is also a result of the industry participants' significant rise in R&D spending.

 

Key Players
 

This report includes a list of numerous Key Players, namely Pfizer Inc (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Danaher. (U.S.), bioMérieux (France), Siemens Healthcare Private Limited (Germany), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.).

 

Market Taxonomy
 

By Product Type
•    Dipsticks
•    Reagents
•    Disposables

 

By Test Type
•    Urine Tests
•    Blood Tests

 

By End User
•    Hospitals, Diagnostic Laboratories
•    Research Laboratories and Institutes
•    Others

 

By Region
•    North America 
o    U.S.
o    Canada
o    Mexico
•    Latin America
o    Brazil
o    Argentina
o    Colombia
o    Peru
o    Chile
o    Venezuela
o    Rest of Latin America
•    Europe
o    Germany
o    France
o    UK
o    Russia
o    Italy
o    Spain
o    Rest of Europe
•    Asia Pacific
o    China    
o    Japan
o    India
o    South Korea
o    Australia
o    New Zealand
o    Singapore
o    Malaysia
o    Rest of Asia Pacific
•    Middle East & Africa
o    Saudi Arabia
o    UAE
o    Egypt
o    Kuwait
o    South Africa
o    Rest Middle East & Africa
 

Global Kidney/Renal Function Test Market
 

1 Introduction    
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope

 

2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources

 

3 Executive Summary
 

4 Global Kidney/Renal Function Test Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing Economic Downturn
4.2.6 Post Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict 
4.3 Porters Five Force Model
4.4 Value Chain Analysis

 

5 Global Kidney/Renal Function Test Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Kidney/Renal Function Test Market Share Analysis, By Product Type
5.3 Global Kidney/Renal Function Test Market Size and Forecast, By Product Type
5.3.1 Dipsticks
5.3.2 Reagents
5.3.3 Disposables

 

6 Global Kidney/Renal Function Test Market, By Test Type
6.1 Y-o-Y Growth Comparison, By Test Type
6.2 Global Kidney/Renal Function Test Market Share Analysis, By Test Type
6.3 Global Kidney/Renal Function Test Market Size and Forecast, By Test Type
6.3.1 Urine Tests
6.3.2 Blood Tests

 

7 Global Kidney/Renal Function Test Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Kidney/Renal Function Test Market Share Analysis, By End User
7.3 Global Kidney/Renal Function Test Market Size and Forecast, By End User
7.3.1 Hospitals, Diagnostic Laboratories
7.3.2 Research Laboratories and Institutes
7.3.3 Others 

 

8 Global Kidney/Renal Function Test Market, By Region
8.1 Global Kidney/Renal Function Test Market Share Analysis, By Region
8.2 Global Kidney/Renal Function Test Market Share Analysis, By Region
8.3 Global Kidney/Renal Function Test Market Size and Forecast, By Region

 

9 North America Kidney/Renal Function Test Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Kidney/Renal Function Test Market Share Analysis, By Product
9.3 North America Kidney/Renal Function Test Market Size and Forecast, By Test Type
9.4 North America Kidney/Renal Function Test Market Size and Forecast, By End User
9.5 North America Kidney/Renal Function Test Market Size and Forecast, By Country
9.5.1 U.S.
9.5.1.1 Market Size and Forecast, By Product 
9.5.1.2 Market Size and Forecast, By Test Type 
9.5.1.3 Market Size and Forecast, By End User 
9.5.2 Canada
9.5.2.1 Market Size and Forecast, By Product 
9.5.2.2 Market Size and Forecast, By Test Type 
9.5.2.3 Market Size and Forecast, By End User
9.5.3 Mexico
9.5.3.1 Market Size and Forecast, By Product 
9.5.3.2 Market Size and Forecast, By Test Type 
9.5.3.3 Market Size and Forecast, By End User 

 

10 Europe Kidney/Renal Function Test Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Kidney/Renal Function Test Market Share Analysis, By Product
10.3 Europe Kidney/Renal Function Test Market Size and Forecast, By Test Type 
10.4 Europe Kidney/Renal Function Test Market Size and Forecast, By End User
10.5 Europe Kidney/Renal Function Test Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1 Market Size and Forecast, By Product 
10.5.1.2 Market Size and Forecast, By Test Type 
10.5.1.3 Market Size and Forecast, By End User
10.5.2 France
10.5.2.1 Market Size and Forecast, By Product 
10.5.2.2 Market Size and Forecast, By Test Type 
10.5.2.3 Market Size and Forecast, By End User
10.5.3 UK
10.5.3.1 Market Size and Forecast, By Product 
10.5.3.2 Market Size and Forecast, By Test Type 
10.5.3.3 Market Size and Forecast, By End User
10.5.4 Russia
10.5.4.1 Market Size and Forecast, By Product 
10.5.4.2 Market Size and Forecast, By Test Type 
10.5.4.3 Market Size and Forecast, By End User
10.5.5 Italy
10.5.5.1 Market Size and Forecast, By Product 
10.5.5.2 Market Size and Forecast, By Test Type 
10.5.5.3 Market Size and Forecast, By End User 
10.6.6 Spain
10.5.6.1 Market Size and Forecast, By Product 
10.5.6.2 Market Size and Forecast, By Test Type 
10.5.6.3 Market Size and Forecast, By End User
10.6.7 Rest of Europe
10.5.7.1 Market Size and Forecast, By Product 
10.5.7.2 Market Size and Forecast, By Test Type 
10.5.7.3 Market Size and Forecast, By End User

 

11 Asia Pacific Kidney/Renal Function Test Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Kidney/Renal Function Test Market Share Analysis, By Product
11.3 Asia Pacific Kidney/Renal Function Test Market Size and Forecast, By Test Type 
11.4 Asia Pacific Kidney/Renal Function Test Market Size and Forecast, By End User
11.5 Asia Pacific Kidney/Renal Function Test Market Size and Forecast, By Country
11.5.1 China
11.5.1.1 Market Size and Forecast, By Product 
11.5.1.2 Market Size and Forecast, By Test Type 
11.5.1.3 Market Size and Forecast, By End User    
11.5.2 Japan
11.5.2.1 Market Size and Forecast, By Product 
11.5.2.2 Market Size and Forecast, By Test Type 
11.5.2.3 Market Size and Forecast, By End User
11.5.3 India
11.5.3.1 Market Size and Forecast, By Product 
11.5.3.2 Market Size and Forecast, By Test Type 
11.5.3.3 Market Size and Forecast, By End User
11.5.4 South Korea
11.5.4.1 Market Size and Forecast, By Product 
11.5.4.2 Market Size and Forecast, By Test Type 
11.5.4.3 Market Size and Forecast, By End User
11.5.5 Australia
11.5.5.1 Market Size and Forecast, By Product 
11.5.5.2 Market Size and Forecast, By Test Type 
11.5.5.3 Market Size and Forecast, By End User
11.5.6 New Zealand
11.5.6.1 Market Size and Forecast, By Product 
11.5.6.2 Market Size and Forecast, By Test Type 
11.5.6.3 Market Size and Forecast, By End User
11.5.7 Singapore
11.5.7.1 Market Size and Forecast, By Product 
11.5.7.2 Market Size and Forecast, By Test Type 
11.5.7.3 Market Size and Forecast, By End User
11.5.8 Malaysia
11.5.8.1 Market Size and Forecast, By Product 
11.5.8.2 Market Size and Forecast, By Test Type 
11.5.8.3 Market Size and Forecast, By End User
11.5.9 Rest of Asia Pacific
11.5.9.1 Market Size and Forecast, By Product 
11.5.9.2 Market Size and Forecast, By Test Type 
11.5.9.3 Market Size and Forecast, By End User

 

12 Latin America Kidney/Renal Function Test Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Kidney/Renal Function Test Market Share Analysis, By Product
12.3 Latin America Kidney/Renal Function Test Market Size and Forecast, By Test Type 
12.4 Latin America Kidney/Renal Function Test Market Size and Forecast, By End User
12.5 Latin America Kidney/Renal Function Test Market Size and Forecast, Country
12.5.1 Brazil
12.5.1.1 Market Size and Forecast, By Product 
12.5.1.2 Market Size and Forecast, By Test Type 
12.5.1.3 Market Size and Forecast, By End User
12.5.2 Argentina
12.5.2.1 Market Size and Forecast, By Product 
12.5.2.2 Market Size and Forecast, By Test Type 
12.5.1.3 Market Size and Forecast, By End User
12.5.3 Colombia
12.5.3.1 Market Size and Forecast, By Product 
12.5.3.2 Market Size and Forecast, By Test Type 
12.5.3.3 Market Size and Forecast, By End User
12.5.4 Peru
12.5.4.1 Market Size and Forecast, By Product 
12.5.4.2 Market Size and Forecast, By Test Type 
12.5.4.3 Market Size and Forecast, By End User
12.5.5 Chile
12.5.5.1 Market Size and Forecast, By Product 
12.5.5.2 Market Size and Forecast, By Test Type 
12.5.5.3 Market Size and Forecast, By End User
12.5.6 Venezuela
12.5.6.1 Market Size and Forecast, By Product 
12.5.6.2 Market Size and Forecast, By Test Type 
12.5.6.3 Market Size and Forecast, By End User
12.5.7 Rest of Latin America
12.5.7.1 Market Size and Forecast, By Product 
12.5.7.2 Market Size and Forecast, By Test Type 
12.5.7.3 Market Size and Forecast, By End User

 

14 Middle East Kidney/Renal Function Test Market Analysis and Forecast (2023-2030)
14.1 Introduction
14.2 Middle East Kidney/Renal Function Test Market Share Analysis, By Product
14.3 Middle East Kidney/Renal Function Test Market Size and Forecast, By Test Type 
14.4 Middle East Kidney/Renal Function Test Market Size and Forecast, By End User
14.5 Middle East Kidney/Renal Function Test Market Size and Forecast, By Country
14.5.1 Saudi Arabia
14.5.1.1 Market Size and Forecast, By Product 
14.5.1.2 Market Size and Forecast, By Test Type 
14.5.1.3 Market Size and Forecast, By End User
14.5.2 UAE
14.5.2.1 Market Size and Forecast, By Product 
14.5.2.2 Market Size and Forecast, By Test Type 
14.5.2.3 Market Size and Forecast, By End User
14.5.3 Egypt
14.5.3.1 Market Size and Forecast, By Product 
14.5.3.2 Market Size and Forecast, By Test Type 
14.5.3.3 Market Size and Forecast, By End User
14.5.4 Kuwait
14.5.4.1 Market Size and Forecast, By Product 
14.5.4.2 Market Size and Forecast, By Test Type 
14.5.4.3 Market Size and Forecast, By End User
14.5.5 South Africa
14.5.5.1 Market Size and Forecast, By Product 
14.5.5.2 Market Size and Forecast, By Test Type 
14.5.5.3 Market Size and Forecast, By End User
14.5.6 Rest Middle East & Africa
14.5.6.1 Market Size and Forecast, By Product 
14.5.6.2 Market Size and Forecast, By Test Type 
14.5.6.3 Market Size and Forecast, By End User

 

15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies

 

16 Company Profiles
16.1 Pfizer Inc (U.S.) 
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 AstraZeneca (U.K.)
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Bristol-Myers Squibb Company (U.S.)
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 F. Hoffmann-La Roche Ltd (Switzerland) 
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Abbott (U.S.)
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Danaher. (U.S.) 
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 bioMérieux (France) 
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies    
16.8 Siemens Healthcare Private Limited (Germany)  
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 BD (U.S.)
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10 Bio-Rad Laboratories, Inc. (U.S.)
 16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies